Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Bone marrow transplantation is used in several haematological
diseases, such as acute and chronic leukaemia, aplastic anaemia, and
severe congenital immunodeficiencies.1 The survival rate
has improved greatly over the past decade.2 Patients who have had successful bone marrow transplantation have peripheral blood
cells originating from the donated bone marrow, and results of
cytogenetic studies of these blood cells will relate to the donor. This
is an important point to note if confusion is to be avoided, as was the
case with two patients who presented to our centre.
Two male patients attended our unit with their spouses for infertility
treatment. The cause of infertility in both cases was intensive
radiotherapy and chemotherapy before allograft bone marrow
transplantation. One patient (case 1) was 28 years old and the other
(case 2) 31 years old. Acute lymphoplastic leukaemia had been diagnosed
in both in 1998. The treatment of choice in both cases is